Gayen Shameek, Ziemba Yonah, Jaiswal Shikha, Frank Adam, Brahmbhatt Yasmin
Thomas Jefferson University, Philadelphia, PA, USA.
Case Rep Gastroenterol. 2016 Nov 25;10(3):728-732. doi: 10.1159/000452201. eCollection 2016 Sep-Dec.
Peritoneal dialysis (PD) is an excellent form of renal replacement therapy for many patients with end-stage renal disease (ESRD). Over 10,000 patients receive PD in the United States [United States Renal Data System: 2015]. PD has superior outcomes compared to hemodialysis in the first 2 years of ESRD [Sinnakirouchenan and Holley: Adv Chronic Kidney Dis 2011;18: 428-432]. However, peritonitis is a known complication and may result in significant morbidity and necessitate transition to hemodialysis, which increases medical costs [Holley and Piraino: Semin Dial 1990;3: 245-248]. We report the first case of a PD patient who underwent endoscopy, colonoscopy and CT angiogram with coil embolization for gastrointestinal bleeding without antibiotic prophylaxis and subsequently developed CDC group EO-4 organism and fungal peritonitis.
腹膜透析(PD)对于许多终末期肾病(ESRD)患者而言是一种出色的肾脏替代治疗方式。在美国,超过10000名患者接受腹膜透析治疗[美国肾脏数据系统:2015年]。在ESRD的头两年,腹膜透析与血液透析相比具有更好的治疗效果[辛纳基鲁切南和霍利:《慢性肾脏病进展》2011年;18:428 - 432]。然而,腹膜炎是一种已知的并发症,可能导致严重的发病情况,并可能需要转为血液透析,这会增加医疗成本[霍利和皮拉伊诺:《透析与人工肾》1990年;3:245 - 248]。我们报告了首例腹膜透析患者,该患者在未进行抗生素预防的情况下接受了内镜检查、结肠镜检查及CT血管造影并进行了弹簧圈栓塞治疗胃肠道出血,随后发生了疾病控制与预防中心(CDC)EO - 4组生物体感染及真菌性腹膜炎。